The Innovative Health Initiative (IHI) is a partnership between the European Union and industry associations representing the sectors involved in healthcare, namely COCIR (medical imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe (pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech Europe (medical technology industry).
IHI is the successor of the Innovative Medicines Initiative (IMI), the world’s largest public-private collaboration in life sciences.
Objectives
The partnership intends to
- help create an EU-wide health research and innovation ecosystem that facilitates translation of scientific knowledge into innovations
- foster the development of safe, effective, people-centred and cost-effective innovations that respond to strategic unmet public health needs
- drive cross-sectoral health innovation for a globally competitive European health industry.
It will cover the entire continuum of care, from prevention and diagnostics to treatment and disease management.
Participation Flanders
The following organisations based in Flanders are partner in ongoing IHI projects (2022 calls):
- ICOMETROX NV in the project 'CLAIMS'
- Janssen Pharmaceutica nv in the project 'IMAGIO' & 'IDERHA
- The European Institute for Innovation through Health Data (I-HD) in 'IDERHA'
- Q1.6 bv in 'IDHERA'
- Johnson & Johnson Medical nv in 'IDHERA'
Governance of IHI: The IHI States Representatives Group consists of representatives of the EU Member States & countries associated to Horizon Europe. The group is consulted on a range of issues, including the draft call topics. In this group, the Flemish government is represented by Kathleen D'Hondt.
Past & current calls for proposals
Since it took off in 2021, IHI has launched several calls of proposals. Information on topics that are in the pipeline can be found on IHI's 'future opportunities' webpage. Information on calls that are currently open can be found on IHI's open calls webpage.
Currently, there is an open call: